Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation

Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation Publisher

Alizadehasl A^{1, 5} ; Ghavamzadeh A² ; Emami AH³ ; Janbabaei G⁴ ; Khodaamorzideh D^{1, 5}

Show Affiliations

1. Cardio-Oncology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
2. Hematology Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
3. Hematology-Oncology Department, Cancer Institute, Imam Khomeini Hospital, School of medicine, Tehran University of Medical Sciences, Tehran, Iran
4. Hematologic Malignancies Research Center, Tehran University of Medical Sciences, Tehran, Iran
5. Cardio-Oncology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

Source: Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation Published:2024

Abstract

This book discusses the epidemiology and the known cardiotoxic effects of chemoradiation agents in addition to newer therapies in hematopoietic stem cell transplantation (HSCT). Recent expert consensus statements from cardiology and hematology/oncology societies are reviewed in regard to risk stratification of the patient based on the type of treatments they are undergoing. Finally, gaps in knowledge are identified with proposed avenues of research that allow for more accurate risk assessment, prediction and potential treatment of the HSCT patient in attenuating the risk of developing cardiovascular comorbidities. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation reveals a picture of effective management of these patients in order to optimize both short- and long-term outcomes of HSCT. It is of considerable interest to all involved or training within this rapidly growing area of cardiology and oncology. © Springer Nature Switzerland AG 2024. All rights reserved.

Style	Citing Format
MLA	Alizadehasl A, et al.. "Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation." Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation, vol. , no. , 2024, pp. 1-291.
APA	Alizadehasl A, Ghavamzadeh A, Emami AH, Janbabaei G, Khodaamorzideh D (2024). Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation, (), 1-291.
Chicago	Alizadehasl A, Ghavamzadeh A, Emami AH, Janbabaei G, Khodaamorzideh D. "Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation." Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation , no. (2024): 1-291.
Harvard	Alizadehasl A et al. (2024) 'Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation', Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation, (), pp. 1-291.
Vancouver	Alizadehasl A, Ghavamzadeh A, Emami AH, Janbabaei G, Khodaamorzideh D. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation. 2024;():1-291.
BibTex	@article{ author = {Alizadehasl A and Ghavamzadeh A and Emami AH and Janbabaei G and Khodaamorzideh D}, title = {Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation}, journal = {Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation}, volume = {}, number = {}, pages = {1-291}, year = {2024} }
RIS	TY - JOUR AU - Alizadehasl A AU - Ghavamzadeh A AU - Emami AH AU - Janbabaei G AU - Khodaamorzideh D TI - Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation JO - Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation VL - IS - SP - 1 EP - 291 PY - 2024 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract